Shinji Taneda Selected Research

Shinji Taneda Research Topics

Disease

13	Type 2 Diabetes Mellitus (MODY) 12/2023 - 01/2015
6	Body Weight (Weight, Body) 12/2023 - 03/2017
3	Amyloidosis 12/2018 - 01/2017
3	Arthritis (Polyarthritis) 01/2007 - 12/2003
2	Insulin Resistance 12/2023 - 11/2022
2	Hypertriglyceridemia 10/2022 - 04/2021
2	Hypoglycemia (Reactive Hypoglycemia) 05/2022 - 03/2017
2	Diabetes Mellitus 08/2021 - 01/2021
2	Inflammation (Inflammations) 07/2004 - 12/2003
1	Albuminuria 11/2022
1	Chronic Renal Insufficiency 11/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2022
1	Hyperglycemia 08/2021
1	Non-alcoholic Fatty Liver Disease 07/2021
1	Weight Loss (Weight Reduction) 07/2021
1	Fatty Liver 07/2021
1	Dyslipidemias (Dyslipidemia) 04/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Adenocarcinoma 08/2008
1	Breast Neoplasms (Breast Cancer) 08/2008
1	Hypothyroidism 12/2007
1	Allergic Rhinitis 09/2007
1	Asthma (Bronchial Asthma) 09/2007
1	Atrophy 06/2006
1	Rheumatoid Arthritis 07/2004
1	Food Hypersensitivity (Food Allergy) 04/2002
1	Experimental Arthritis 02/2002

Drug/Important Bio-Agent (IBA)

7	Insulin (Novolin)FDA Link 05/2022 - 01/2015
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2017
4	LipidsIBA 12/2023 - 01/2021
4	semaglutideIBA 12/2023 - 03/2021
3	dulaglutideIBA 01/2023 - 03/2021
3	AntigensIBA 01/2007 - 12/2003
2	Liraglutide FDA Link 01/2023 - 03/2021
2	Semaphorins (Semaphorin)IBA 01/2023 - 03/2021
2	Glucagon-Like Peptide-1 ReceptorIBA 11/2022 - 03/2021
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2022 - 04/2021
2	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 10/2022 - 04/2021
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2021
2	SodiumIBA 08/2021 - 07/2021
2	Triglycerides (Triacylglycerol)IBA 07/2021 - 04/2021
2	insulin aspart drug combination insulin degludecIBA 03/2017 - 01/2015
2	insulin aspart protamine drug combination 30:70 insulin aspartIBA 03/2017 - 01/2015
2	Vehicle Emissions (Emissions, Vehicle)IBA 08/2008 - 02/2002
2	Testosterone (Sustanon)FDA Link 12/2007 - 06/2006
2	RolipramIBA 01/2007 - 07/2004
2	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 04/2002 - 02/2002
1	EnzymesIBA 12/2023
1	imegliminIBA 11/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2022
1	AlbuminsIBA 11/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2022
1	CreatinineIBA 11/2022
1	Hemoglobins (Hemoglobin)IBA 11/2022
1	Metformin (Glucophage)FDA LinkGeneric 11/2022
1	Fibric Acids (Fibrates)IBA 10/2022
1	Sodium-Glucose Transport ProteinsIBA 05/2022
1	IncretinsIBA 01/2022
1	CanagliflozinIBA 08/2021
1	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 08/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 07/2021
1	dapagliflozinIBA 07/2021
1	ThiazolidinesIBA 07/2021
1	Pioglitazone (Actos)FDA Link 07/2021
1	Glucagon-Like Peptides (Enteroglucagon)IBA 03/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2021
1	hydroxide ionIBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Estrogen Receptor alphaIBA 08/2008
1	CarcinogensIBA 08/2008
1	Estrogens (Estrogen)FDA Link 08/2008
1	Gasoline (Diesel Fuel)IBA 08/2008
1	NitrophenolsIBA 08/2008
1	2-mercapto-1-methylimidazoleIBA 12/2007
1	Drinking WaterIBA 12/2007
1	Methimazole (Thiamazole)FDA LinkGeneric 12/2007
1	Inhibins (Inhibin)IBA 12/2007
1	CorticosteroneIBA 12/2007
1	Butylated Hydroxytoluene (BHT)IBA 09/2007
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2007
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2007
1	Immunoglobulin G (IgG)IBA 12/2003
1	Interleukin-10 (Interleukin 10)IBA 12/2003
1	Proteins (Proteins, Gene)FDA Link 04/2002

Therapy/Procedure

8	Glycemic Control 11/2022 - 01/2017
4	Therapeutics 10/2022 - 01/2017